top of page
Home
About Us
Leadership
Advisors
Partnerships
Our Technology
Flex-NK Bispecific Antibodies
iNK & CAR-iNK Cells
Pipeline
Investors & Media
News & Events
Resources
Media
Contact Us
More
Use tab to navigate through the menu items.
Scientific Publications
(Multi-Specific Antibodies)
Design and Validation of a Novel Generic Platform for the Production of Tetravalent IgG1-like Bispecific Antibodies.
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46
NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy
NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis
bottom of page